WHAM13 - Search Results
UofR gets new grant for HIV research
Rochester, N.Y. The University of Rochester is getting a $1 million grant from the Department of Health and Human Services National Institute of Allergy and Infectious Diseases for the research and treatment on the prevention of HIV, Senators Charles Schumer and Kirsten Gillibrand have announced today.
The funding will go toward developing better treatment methods and better standards of care for people who are living with HIV.
It would also set up clinical trials for preventative HIV vaccines at the UofR Clinical Trials Unit.
The University of Rochester is a hub for nationally-recognized technology research and this grant will add to that reputation, Senator Schumer said in a statement. The funding will advance the University of Rochesters groundbreaking research in HIV treatment and prevention, keep our nations top scientists flocking to the Rochester area, and most importantly, it may lead to the development of an HIV vaccine.
The grant is a renewal of a research program that the UR Infectious Diseases Division has had since 1987. It funds the UR HIV/AIDS Clinical Trials Unit, so that the unit can conduct trials until 2018.
The University of Rochester is home to world-class medical research, Senator Gillibrand said in a statement. When we invest in new research for HIV, we can unlock discoveries for new treatments and help save more lives, attract even more bright minds to Rochester, and support new economic growth.